J Neurol Neurosurg Psychiatry

1. MARRIE RA, Fisk JD, Walld R, Bolton JM, et al
   Prescription opioid use in multiple sclerosis.
   J Neurol Neurosurg Psychiatry. 2022 Aug 26. pii: jnnp-2022-329508.
   

   >> Share

   
   
2. CHO EB, Yeo Y, Jung JH, Jeong SM, et al
   Risk of stroke in multiple sclerosis and neuromyelitis optic spectrum disorder: a Nationwide cohort study in South Korea.
   J Neurol Neurosurg Psychiatry. 2022 Aug 26. pii: jnnp-2022-329628.
   

   >> Share

   
   

   
   Mult Scler

3. MEATON I, Altokhis A, Allen CM, Clarke MA, et al
   Paramagnetic rims are a promising diagnostic imaging biomarker in multiple sclerosis.
   Mult Scler. 2022 Aug 26:13524585221118677. doi: 10.1177/13524585221118677.
   

   >> Share

   
   
4. BROWNLEE WJ, Wolf C, Hartung HP, Dingermann T, et al
   Use of follow-on disease-modifying treatments for multiple sclerosis: Consensus recommendations.
   Mult Scler. 2022 Aug 24:13524585221116269. doi: 10.1177/13524585221116269.
   

   >> Share

   
   
5. ALTOKHIS AI, Hibbert AM, Allen CM, Mougin O, et al
   Longitudinal clinical study of patients with iron rim lesions in multiple sclerosis.
   Mult Scler. 2022 Aug 24:13524585221114750. doi: 10.1177/13524585221114750.
   

   >> Share

   
   
6. YOUNG CA, Mills RJ, Langdon D, Rog DJ, et al
   Measuring coping in multiple sclerosis: The Coping Index-MS.
   Mult Scler. 2022 Aug 24:13524585221114004. doi: 10.1177/13524585221114004.
   

   >> Share

   
   

   
   N Engl J Med

7. STEINMAN L, Fox E, Hartung HP, Alvarez E, et al
   Ublituximab versus Teriflunomide in Relapsing Multiple Sclerosis.
   N Engl J Med. 2022;387:704-714.
   

   >> Share

   
   

   
   Neurology

8. HWANG S, Garcia-Dominguez MA, Fitzgerald KC, Saylor DR, et al
   Association of Multiple Sclerosis Prevalence With Sociodemographic, Health Systems, and Lifestyle Factors on a National and Regional Level.
   Neurology. 2022 Aug 24. pii: WNL.0000000000200962.
   

   >> Share

   
   
9. BRENTON JN, Florenzo B, Koshiya H, Min S, et al
   Six-Minute Walk as a Measure of Walking Capacity and Endurance in Patients With Pediatric-Onset Multiple Sclerosis.
   Neurology. 2022 Aug 19. pii: WNL.0000000000201098.
   

   >> Share

   
   

   
   Neurosci Lett

10. SUN M, Liu N, Sun J, Li X, et al
    Curcumin regulates anti-inflammatory responses by AXL/JAK2/STAT3 signaling pathway in experimental autoimmune encephalomyelitis.
    Neurosci Lett. 2022;787:136821.
    

    >> Share

    
    

    
    Proc Natl Acad Sci U S A

11. MEYER T, Shimon D, Youssef S, Yankovitz G, et al
    NAD(+) metabolism drives astrocyte proinflammatory reprogramming in central nervous system autoimmunity.
    Proc Natl Acad Sci U S A. 2022;119:e2211310119.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share